Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
Amcasertib (BBI503) is a kinase inhibitor that inhibits signaling pathways that regulate survival of cancer stem cells, resulting in decreased cancer cell growth (NCI Drug Dictionary).
|CAS Registry Number||1129403-56-0|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Amcasertib + Sorafenib||Amcasertib Sorafenib||0||1|